International Journal of Molecular Sciences · 2019 · 20 citations · 16 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryNeuropharmacologyEnzyme InhibitionHit-to-lead OptimizationLead Compound DesignStructure-activity Relationship AnalysisAcetylation PatternBiological Evaluation ReportFive-membered HeterocyclesNeuroblastoma Biology
Thiazolidinedione is a five-membered heterocycle that is widely used in drug discovery endeavors. In this study, we report the design, synthesis, and biological evaluation of a series of thiazolidinedione-based HDAC6 inhibitors. In particular, compound 6b exerts an excellent inhibitory activity against HDAC6 with an IC50 value of 21 nM, displaying a good HDAC6 selectivity over HDAC1. Compound 6b dose-dependently induces the acetylation level of α-tubulin via inhibition of HDAC6 in human neuroblastoma SH-SY5Y cell line. Moreover, compound 6b efficiently reverses methamphetamine-induced morphology changes of SH-SY5Y cells via regulating acetylation landscape of α-tubulin. Collectively, compound 6b represents a novel HDAC6-isoform selective inhibitor and demonstrates promising therapeutic potential for the treatment of methamphetamine addiction.
16
HDAC‐6 interacts with and deacetylates tubulin and microtubules in vivo
Yu Zhang, Na Li, Cécile Caron et al. · The EMBO Journal · 2003 · 726 citations · Full text
Fenfen Li, Rui Wu, Xin Cui et al. · Journal of Biological Chemistry · 2016 · 126 citations · Full text
Anti Kalda, Lenne‐Triin Heidmets, Hai‐Ying Shen et al. · Behavioural Brain Research · 2007 · 87 citations · Full text
Methamphetamine abuse impairs motor cortical plasticity and function
Xiaodan Huang, Yung‐Yi Chen, Yingqiang Shen et al. · Molecular Psychiatry · 2017 · 81 citations · Full text